Solution-Focused Brief Therapy for Support of Psychological Distress in Adolescent and Young Adult Cancer Survivors

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15-39
SponsorUniversity of Michigan Rogel Cancer Center

About this trial

This clinical trial evaluates the how well a virtually delivered solution-focused brief therapy (SFBT-C) works to decrease adolescent and young adult cancer survivors' psychological distress in comparison to enhanced treatment-as-usual care. Cancer and its treatment can have immediate and long-term impacts on adolescent and young adult cancer survivor's lives, including education and employment, financial stability, sexual health, and social, romantic, and family relationships. Consequently, many adolescent and young adult cancer survivors report psychological distress, often manifesting as depression and anxiety, and may benefit from psychotherapy to improve their engagement with medical treatment and overall quality of life. SFBT-C is a theory-driven and brief hope-based psychotherapy designed for the unique psychosocial needs facing adolescent and young adult cancer survivors. Undergoing SFBT-C may work better than treatment-as-usual care for the support of psychological distress in adolescent and young adult cancer survivors.

Eligibility criteria

Qualifiers

15 - 39 years old

Diagnosed with cancer

Receiving active cancer care (6 weeks post initial diagnosis to control for emotional responses to normative stressors) or within 5 years of post-treatment survivorship

Experiencing psychological distress (i.e., a t-score >= 57 on the Brief Symptom Inventory - 18 items [BSI-18])

Disqualifiers

End-of-life care

> 5 years into the post-treatment survivorship

Major physical challenges (e.g., hearing loss, developmental delay)

Acute mental health conditions (e.g., active psychosis, suicide risk)

Trial design

Treatments tested in this trial

  • Behavioral Intervention
  • Best Practice
  • Communication Intervention
  • Discussion
  • Health Promotion and Education
  • Health Promotion and Education
  • Interview
  • Questionnaire Administration

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Michigan Rogel Cancer Center

Lead sponsor

Children's Cancer Research Fund

Collaborator